OCS logo

Oculis Holding AG

OCS
Healthcare|Biotechnology|CH
$7.49
+0.66 (+9.66%)
DCF Value
$1.82
Tangible Book / Share
$3.39
Cash / Share
$0.00

Ownership Breakdown

64.8%
Float
61.7M
Shares Outstanding
40.0M
Float Shares

Major Holders (16)

Combined: 76.7%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
LSP 7 Cooperatieve U.A.Other11.80%6,950,294Apr 29, 202613D/G
LSP 7 Management B.V.Other11.80%6,950,294Apr 29, 202613D/G
Nan Fung Life Sciences Holdings LimitedCorporation4.90%2,815,476Nov 14, 202513D/G
NF Investment Holdings LimitedCorporation4.90%2,815,476Nov 14, 202513D/G
Nan Fung Group Holdings LimitedCorporation4.90%2,815,476Nov 14, 202513D/G
BVCF IV, L.P.Partnership4.14%2,436,902Mar 27, 202613D/G
BeyeotechCorporation4.14%2,436,902Mar 27, 202613D/G
Zhi YangIndividual4.14%2,436,902Mar 27, 202613D/G
BVCF IV GP, Ltd.Partnership4.14%2,436,902Mar 27, 202613D/G
Pivotal Life Sciences Holdings LimitedCorporation4.00%2,300,774Nov 14, 202513D/G
Pivotal bioVenture Partners Fund I, L.P.Partnership4.00%2,300,774Nov 14, 202513D/G
Pivotal bioVenture Partners Fund I G.P., L.P.Partnership4.00%2,300,774Nov 14, 202513D/G
Pivotal bioVenture Partners Fund I U.G.P. Ltd.Corporation4.00%2,300,774Nov 14, 202513D/G
Pivotal Partners LtdCorporation4.00%2,300,774Nov 14, 202513D/G
NFLS Beta LimitedCorporation0.90%514,702Nov 14, 202513D/G
NFLS Platform Holdings LimitedCorporation0.90%514,702Nov 14, 202513D/G